Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
04/24/20241:30AMGlobeNewswire Inc.Nicox : Deuxième convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 6 mai 2024 et désignation d’un mandataire ad hocLSE:0RCQNicox Sa
04/24/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
04/24/20241:30AMGlobeNewswire Inc.Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agentEU:ALCOXNicox SA
04/24/20241:30AMGlobeNewswire Inc.Q1 2024 results: KPN delivers solid start to the yearLSE:31QXKon. Kpn
04/24/20241:30AMGlobeNewswire Inc.Q1 2024 results: KPN delivers solid start to the yearTG:KPNKoninklijke KPN NV
04/24/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
04/24/20241:30AMGlobeNewswire Inc.Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agentCOX
04/24/20241:30AMGlobeNewswire Inc.Nicox : Deuxième convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 6 mai 2024 et désignation d’un mandataire ad hocEU:ALCOXNicox SA
04/24/20241:30AMGlobeNewswire Inc.Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agentTG:NXOANicox SA
04/24/20241:30AMBusiness WireMotorK: Q1 2024 Trading Update, €1.7 Million Reserved Capital Increase, and Helen Protopapas's Appointment as New Non-Executive Director
04/24/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
04/24/20241:30AMGlobeNewswire Inc.Nicox : Deuxième convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 6 mai 2024 et désignation d’un mandataire ad hocTG:NXOANicox SA
04/24/20241:30AMGlobeNewswire Inc.Q1 2024 results: KPN delivers solid start to the yearEU:KPNKoninklijke KPN NV
04/24/20241:30AMGlobeNewswire Inc.Transaction in Own SharesTG:6E2Endeavour Mining Corp
04/24/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
04/24/20241:30AMGlobeNewswire Inc.Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agentLSE:0RCQNicox Sa
04/24/20241:23AMBusiness WireGoFundMe se expande a México
04/24/20241:20AMBusiness WireAir Liquide continues its trajectory with another solid quarter, combining sales growth, performance improvement and investment momentumNYSE:AIC3 AI Inc
04/24/20241:20AMBusiness WireAir Liquide poursuit sa trajectoire en réalisant à nouveau un trimestre solide, combinant croissance des ventes, amélioration de la performance et dynamique d'investissementNYSE:AIC3 AI Inc
04/24/20241:18AMPR Newswire (Canada)Xinhua Silk Road : La marque chinoise de baijiu Wuliangye met en lumière les échanges culturels entre la Chine et le Chili par l'entremise d'une tournée mondiale élaborée
04/24/20241:15AMBusiness WireEurofins Achieves Organic Growth of 6.8% in Q1 2024, Ahead of Its ObjectivesNYSE:ERFEnerplus Corporation
04/24/20241:03AMBusiness WireKalray Joins Arm Total Design, Extending Collaboration With Arm on Accelerated AI ProcessingEU:ALKALKALRAY SA
04/24/20241:03AMBusiness WireKALRAY DEVIENT MEMBRE DU PROGRAMME « ARM TOTAL DESIGN », RENFORÇANT SA COLLABORATION AVEC ARM SUR L’IA ET L’ACCÉLÉRATION DU TRAITEMENT DES DONNÉESEU:ALKALKALRAY SA
04/24/20241:00AMGlobeNewswire Inc.NaaS Technology and its Parent Company, NewLink, Join the Open Invention Network CommunityNASDAQ:NAASNaaS Technology Inc
04/24/20241:00AMGlobeNewswire Inc.Melexis Q1 2024 résultats – Chiffre d'affaires de 241.8 millions d'euros au premier trimestreTG:MEXMelexis
04/24/20241:00AMGlobeNewswire Inc.IMCD Spain expands its Pharmaceuticals presence with the acquisition of CobapharmaTG:INXIMCD NV
04/24/20241:00AMGlobeNewswire Inc.Melexis Q1 2024 results – First quarter sales of 241.8 million EUREU:MELEMelexis
04/24/20241:00AMGlobeNewswire Inc.Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidanceEU:IPNIpsen SA
04/24/20241:00AMGlobeNewswire Inc.Melexis Q1 2024 résultats – Chiffre d'affaires de 241.8 millions d'euros au premier trimestreEU:MELEMelexis
04/24/20241:00AMGlobeNewswire Inc.BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023EU:BIOSBiosenic